A phase 2 trial of Cloudbreak Pharma’s eye disease prospect CBT-004 has hit its primary endpoint, teeing the company up to advance the candidate and talk to the FDA about the route to approval.

Proceeds Will be Utilized to Pay Down All Unsecured Debt and Approximately 45% of Secured Debt UpHealth Will Focus on TTC Healthcare, A Growing, Cash Flow Positive Behavioral Health Business DELRAY ...

GTCR has announced it will acquire Cloudbreak Health from UpHealth for $180 million. Cloudbreak, based in Columbus, Ohio, is a provider of healthcare-focused language interpretation services. Founded ...

Leading video-focused language interpretation service provider to become independent company Headquartered in Columbus, OH, Cloudbreak is a leading video-focused language interpretation service ...

Good morning, Nina Lindholm here with the Friday Wire. The outlook on M&A in foodservice is trending upwards, leading to a string of private equity deals in the sector, my colleague Rafael Canton ...

Leading video-focused language interpretation service provider to become independent company CHICAGO, Nov. 16, 2023 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has ...

DELRAY BEACH, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (UPH), today announced that it has entered into a definitive agreement to sell its wholly-owned subsidiary Cloudbreak Health, LLC ( ...